Sent to 20 readers
Race to AGI Daily Digest - Saturday, June 6, 2026
Share:
TLDR
An AI-designed universal coronavirus vaccine passed its first human trial, moving AI from protein design to the clinic.
Anthropic’s $35B compute financing with Apollo and Blackstone turns GPU access into a structured financial asset.
Flourish raised $500M for brain-inspired low-power AI, challenging the dominance of traditional chip architectures.
Ramp’s $750M round for AI token spend controls brings CFOs directly into the AI governance loop.
Core chip names like ARM, Intel, Qualcomm, AMD, and Baidu dropped sharply, even as demand for smarter, cheaper compute grows.
The Full Story
Following Monday’s defense deals, Tuesday’s near‑trillion Anthropic IPO plans, and the Trump AI order we talked about midweek, today’s question is sharper: who actually controls the resources that steer this whole thing?
On the tech front, AI just cleared a new kind of bar. An AI‑designed universal coronavirus vaccine has passed its first human trial. That’s not a toy model benchmark; it’s a sign that AI‑guided design is starting to land in real biology and public health. AI‑designed universal coronavirus vaccine clears trial ->
At the same time, the bottleneck everyone feels—compute—is being financialized. Anthropic locked in a $35B compute financing package from Apollo Global Management and Blackstone, basically pre‑buying years of GPU access and turning it into a structured asset. Anthropic’s $35B compute deal -> It sits on top of their IPO plans from earlier in the week and doubles down on the “Wall Street as co‑pilot” storyline. Anthropic company profile ->
Not everyone wants more of the same GPUs, though. Flourish raised $500M from Lux Capital, GV, Groq, and Cerebras to build brain‑inspired, low‑power AI. The bet is simple: if ARM, Intel, Qualcomm, and AMD are all down double digits today, maybe the next edge belongs to architectures that sip power instead of guzzling it. Flourish’s $500M brain-inspired AI round ->
Meanwhile, governance is getting pulled into spreadsheets. Ramp raised $750M to build AI token spend controls so CFOs can actually see and cap what all these agents and apps are burning. Ramp’s $750M AI spend control raise -> That dovetails with Thursday’s agent‑monitoring story: if Anthropic is warning that models are learning to build models and calling for a global pause mechanism, someone has to watch the meter too. Anthropic’s global pause mechanism call ->
So by Saturday, the picture is clear: states are setting soft rules, labs are pushing into bio and self‑improvement, and capital is quietly deciding who gets the chips, who builds new kinds of chips, and who can afford to keep their agents running.
Get This Delivered Daily
Join thousands of AI professionals who start their day with Race to AGI.